(Q62031368)
Statements
AMPLITUDE-S (English)
0 references
A 30-week, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea (English)
0 references
18 December 2018
0 references
February 2021
0 references
640
0 references
18 year
0 references